A putative binding model of nitazene derivatives at the μ-opioid receptor
Nitazenes are a class of novel synthetic opioids with exceptionally high potency. Currently, an experimental structure of μOR-opioid receptor (μOR) in complex with a nitazene is lacking. Here we used a suite of computational tools, including consensus docking, conventional molecular dynamics (MD) and metadynamics simulations, to investigate the μOR binding modes of nitro-containing meto-, eto-, proto-, buto-, and isotonitazenes and nitro-less analogs, metodes-, etodes-, and protodesnitazenes. Docking generated three binding modes, whereby the nitro-substituted or unsubstituted benzimidazole group extends into SP1 (subpocket 1 between transmembrane helix or TM 2 and 3), SP2 (subpocket 2 between TM1, TM2, and TM7) or SP3 (subpocket 3 between TM5 and TM6). Simulations suggest that etonitazene and likely also other nitazenes favor the SP2-binding mode. Comparison to the experimental structures of μOR in complex with BU72, fentanyl, and mitragynine pseudoindoxyl (MP) allows us to propose a putative model for μOR-ligand recognition in which ligand can access hydrophobic SP1 or hydrophilic SP2, mediated by the conformational change of Gln124<sup>2.60</sup>. Interestingly, in addition to water-mediated hydrogen bonds, the nitro group in nitazenes forms a π-hole interaction with the conserved Tyr75<sup>1.39</sup>. Our computational analysis provides new insights into the mechanism of μOR-opioid recognition, paving the way for investigations of the structure-activity relationships of nitazenes.
Authors
- Lidiya Stavitskaya (ORCID: https://orcid.org/0000-0002-6307-2314)
- Lei Shi (ORCID: https://orcid.org/0000-0002-4137-096X)
- Georgios Skiniotis (ORCID: https://orcid.org/0000-0003-0238-7846)
- Joseph Clayton (ORCID: https://orcid.org/0000-0002-2652-5994)
- Michael J. Robertson (ORCID: https://orcid.org/0000-0003-2610-680X)
- Jana Shen (ORCID: https://orcid.org/0000-0002-3234-0769)
- Michael Michaelides (ORCID: https://orcid.org/0000-0003-0398-4917)
Institutions
- University of Maryland, Baltimore (US)
- National Institute on Drug Abuse (US)
- Center for Drug Evaluation and Research (US)
- Stanford University (US)
Publication Details
- Journal
- Neuropharmacology
- Published
- 2025-04-03
- DOI
- https://doi.org/10.1016/j.neuropharm.2025.110437
- Citations
- 6
- Primary Topic
- Receptor Mechanisms and Signaling
- Type
- article
- Field-Weighted Citation Impact
- 4.84
Funders
- U.S. Department of Energy
- National Institutes of Health
- U.S. Food and Drug Administration
- Oak Ridge Institute for Science and Education